[Antispasmodics in obstetrics: myth or reality (author's transl)].
D002086:Butylscopolammonium Bromide / Q000627:therapeutic use; D003009:Clorazepate Dipotassium / Q000627:therapeutic use; D004177:Dipyrone / Q000627:therapeutic use; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D008614:Meperidine / Q000627:therapeutic use; D008787:Metoclopramide / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use*; D010696:Phloroglucinol / Q000627:therapeutic use; D011761:Pyrrolidonecarboxylic Acid / Q000627:therapeutic use; D014590:Uterine Contraction / Q000187:drug effects*
D004338:Drug Combinations; D010276:Parasympatholytics; C020432:dypyrone, hyoscine butylbromide drug combination; D002086:Butylscopolammonium Bromide; D003009:Clorazepate Dipotassium; D004177:Dipyrone; D008614:Meperidine; D010696:Phloroglucinol; D008787:Metoclopramide; D011761:Pyrrolidonecarboxylic Acid
Les antispasmodiques en obstétrique: mythe ou réalité.